Viatris Inc. (VTRS)
NASDAQ: VTRS
· Real-Time Price · USD
10.24
-0.21 (-2.01%)
At close: Sep 10, 2025, 3:59 PM
10.44
1.95%
Pre-market: Sep 11, 2025, 04:00 AM EDT
Viatris Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brands Revenue | 2.28B | 2.12B | 4.53B | 2.36B | 2.36B | 2.31B | 2.4B | 2.53B | 2.44B | 2.42B | 2.31B | 2.54B | 2.48B | 2.55B | 2.61B | 2.8B | 2.7B | 2.72B |
| Brands Revenue Growth | +7.92% | -53.26% | +91.73% | -0.04% | +2.34% | -3.88% | -5.16% | +3.62% | +1.01% | +4.68% | -8.98% | +2.30% | -2.78% | -2.21% | -6.82% | +3.75% | -0.84% | n/a |
| Generics Revenue | 1.28B | 1.13B | 2.77B | 1.38B | 1.42B | 1.34B | 1.87B | 1.23B | 1.33B | 1.16B | 1.31B | 1.21B | 1.27B | 1.23B | 1.37B | 1.39B | 1.53B | 1.35B |
| Generics Revenue Growth | +14.05% | -59.37% | +101.50% | -3.30% | +5.83% | -28.23% | +52.74% | -7.48% | +14.01% | -11.07% | +8.33% | -4.78% | +2.77% | -10.04% | -1.04% | -9.28% | +13.41% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Developed Markets Segment Revenue | 2.13B | 1.9B | 2.18B | 2.3B | 2.32B | 2.17B | 2.32B | 2.41B | 2.35B | 2.17B | 2.38B | 2.43B | 2.48B | 2.48B | 2.56B | 2.66B | 2.64B | 2.57B |
| Developed Markets Segment Revenue Growth | +12.17% | -12.83% | -5.25% | -0.88% | +7.10% | -6.63% | -3.71% | +2.32% | +8.45% | -8.89% | -2.03% | -1.92% | +0.12% | -3.31% | -3.58% | +0.59% | +2.68% | n/a |
| Emerging Markets Segment Revenue | 556.9M | 523.1M | 522.7M | 533.2M | 578.1M | 626.4M | 619.1M | 642.5M | 648.1M | 641.9M | 580.6M | 678.9M | 650.9M | 705.2M | 727.5M | 792.5M | 870M | 754.7M |
| Emerging Markets Segment Revenue Growth | +6.46% | +0.08% | -1.97% | -7.77% | -7.71% | +1.18% | -3.64% | -0.86% | +0.97% | +10.56% | -14.48% | +4.30% | -7.70% | -3.07% | -8.20% | -8.91% | +15.28% | n/a |
| Japan, Australia And New Zealand Segment Revenue | 306.7M | 277.1M | 523.1M | 561.8M | 539M | 543.9M | 515.3M | 548.4M | 532.1M | 564.6M | 505.8M | 574M | 548.3M | 573.1M | 503.8M | 566.8M | 550.3M | 591.9M |
| Japan, Australia And New Zealand Segment Revenue Growth | +10.68% | -47.03% | -6.89% | +4.23% | -0.90% | +5.55% | -6.04% | +3.06% | -5.76% | +11.63% | -11.88% | +4.69% | -4.33% | +13.76% | -11.12% | +3.00% | -7.03% | n/a |
| Greater China Segment Revenue | 588.9M | 555.5M | 338M | 344.3M | 349.6M | 317.8M | 372.3M | 334.5M | 375.5M | 342.2M | 398.5M | 383M | 427.1M | 423.8M | 539.2M | 505.3M | 501M | 481.9M |
| Greater China Segment Revenue Growth | +6.01% | +64.35% | -1.83% | -1.52% | +10.01% | -14.64% | +11.30% | -10.92% | +9.73% | -14.13% | +4.05% | -10.33% | +0.78% | -21.40% | +6.71% | +0.86% | +3.96% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 31, 2019 | Sep 29, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 30, 2018 | Sep 29, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 30, 2017 | Sep 29, 2017 | Jun 29, 2017 | Mar 30, 2017 | Dec 30, 2016 | Sep 29, 2016 | Jun 29, 2016 | Mar 30, 2016 | Dec 30, 2015 | Sep 29, 2015 | Jun 29, 2015 | Mar 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 928.7M | 948.1M | 1.05B | 1B | 1.04B | 1.02B | 1.61B | 1.05B | 1.03B | 958.9M | 1.27B | 1.02B | 981.1M | 915.3M | 1.08B | 1.05B | 1.2B | 1.19B | 1.36B | 658.4M | 719.4M | 605.4M | 654.4M | 632.7M | 668.6M | 607.9M | 632.9M | 577.3M | 623.3M | 607.5M | 659M | 664.1M | 620.5M | 630.8M | 708.5M | 656.9M | 581.4M | 549.3M | 596.2M | 537.1M | 564.2M | 483.2M |
| Selling, General, and Administrative Revenue Growth | -2.05% | -9.42% | +4.32% | -3.24% | +1.92% | -36.64% | +52.43% | +2.09% | +7.61% | -24.22% | +24.39% | +3.69% | +7.19% | -15.48% | +2.64% | -12.43% | +1.54% | -12.85% | +106.77% | -8.48% | +18.83% | -7.49% | +3.43% | -5.37% | +9.99% | -3.95% | +9.63% | -7.38% | +2.60% | -7.81% | -0.77% | +7.03% | -1.63% | -10.97% | +7.86% | +12.99% | +5.84% | -7.87% | +11.00% | -4.80% | +16.76% | n/a |
| Research and Development Revenue | 218.8M | 222M | 206.5M | 198.4M | 204.1M | 199.7M | 202.8M | 211.2M | 208.3M | 182.9M | 182.4M | 174.9M | 162.6M | 142.3M | 267.2M | 152.1M | 147.7M | 184.1M | 154.8M | 129.8M | 156.3M | 114.2M | 151.8M | 167.9M | 147.6M | 172.6M | 148.8M | 144.1M | 206.7M | 204.9M | 202.4M | 182.3M | 181.1M | 217.5M | 194.6M | 199.1M | 179.5M | 253.6M | 159M | 174.8M | 168.2M | 169.9M |
| Research and Development Revenue Growth | -1.44% | +7.51% | +4.08% | -2.79% | +2.20% | -1.53% | -3.98% | +1.39% | +13.89% | +0.27% | +4.29% | +7.56% | +14.27% | -46.74% | +75.67% | +2.98% | -19.77% | +18.93% | +19.26% | -16.95% | +36.87% | -24.77% | -9.59% | +13.75% | -14.48% | +15.99% | +3.26% | -30.29% | +0.88% | +1.24% | +11.03% | +0.66% | -16.74% | +11.77% | -2.26% | +10.92% | -29.22% | +59.50% | -9.04% | +3.92% | -1.00% | n/a |